Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life

Wu Huan-lin; Wang Xia; Li Xin-mei; Luo Wen-jie; Deng Tie-tao

doi:10.1007/BF02836499

Your Location：

Home >

Browse articles >

Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life

OriginalPaper | Updated：2021-08-27

- Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life
- Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life
- 中国结合医学杂志（英文版） 2005年11卷第3期页码：173-178
- Affiliations：
  
  1. Heart Center, Guangdong Hospital of Traditional Chinese Medicine,Guangzhou
  2. Guangzhou University of Traditional Chinese Medicine,China
- Author bio：
- Funds：
  
  Supported by Department of Science and Technology of Guangdong Province’s Document (No. 281)
- DOI：10.1007/BF02836499
  中图分类号：
- 纸质出版日期：2005，
Scan for full text
Huan-lin, W., Xia, W., Xin-mei, L. et al. Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life., Chin. J. Integr. Med. 11, 173–178 (2005). https://doi.org/10.1007/BF02836499

Wu Huan-lin, Wang Xia, Li Xin-mei, et al. Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life[J]. Chinese Journal of Integrative Medicine, 2005,11(3):173-178.
Huan-lin, W., Xia, W., Xin-mei, L. et al. Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life., Chin. J. Integr. Med. 11, 173–178 (2005). https://doi.org/10.1007/BF02836499 DOI：

Wu Huan-lin, Wang Xia, Li Xin-mei, et al. Trial study on DENG Tie-tao’s Coronary Heart Disease Capsules in improving patients’ quality of life[J]. Chinese Journal of Integrative Medicine, 2005,11(3):173-178. DOI： 10.1007/BF02836499.

摘要

Objective: To assess the efficacy of the Coronary Heart Disease (CHD) Capsules worked out by Prof. Deng — in improving quality of life of CHD patients of qi deficiency with phlegm and blood stasis syndrome.Method: According to the WHOs diagnosis criteria of CHD

a total of 93 stable angina patients were divided into 3 groups using the single blinded method. The groups were evenly distributed into CHD Capsule treated group (CHDC)

isosorbide dinitrate control group (ID)

and Compound Prescription Danshen Droplet Pills control group (CPDDP). Two courses of treatment lasting for 6 months were given. During the courses of treatment

the following parameters were observed: clinical symptoms of angina pectoris

ECG change

treadmill exercise test

36 items in short form of health survey (SF-36) and Seattle Angina Questionnaire (SAQ) scale.Results: After 6 months of treatment

all the three groups showed good curative effect in angina pectoris

ECG and treadmill exercise test

differences between them had no statistical significance. The CHDC group showed a better result in nitro-glycerine stopping or alleviation rate and in improving symptoms than the other groups (P<0.05). The general health

vitality

role-emotional

mental health and reported health transition in the CHDC group were significantly better than those in the control groups (P< 0.05). The scores in physiological functioningrole

physiological function and pain alleviation were not different among the three groups.Conclusion: Prof. DENG Tie-tao’s CHDC is effective in treating CHD with qi deficiency

phlegm and blood stasis and also in improving the quality of life. CHDC is more suitable to be used in long-term treatment than isosorbide dinitrate. The SF-36 and SAQ can be used to appraise the curative effect of traditional Chinese medicine agents for CHD angina pectoris.

Abstract

a total of 93 stable angina patients were divided into 3 groups using the single blinded method. The groups were evenly distributed into CHD Capsule treated group (CHDC)

isosorbide dinitrate control group (ID)

and Compound Prescription Danshen Droplet Pills control group (CPDDP). Two courses of treatment lasting for 6 months were given. During the courses of treatment

the following parameters were observed: clinical symptoms of angina pectoris

ECG change

treadmill exercise test

36 items in short form of health survey (SF-36) and Seattle Angina Questionnaire (SAQ) scale.Results: After 6 months of treatment

all the three groups showed good curative effect in angina pectoris

ECG and treadmill exercise test

vitality

role-emotional

mental health and reported health transition in the CHDC group were significantly better than those in the control groups (P< 0.05). The scores in physiological functioningrole

physiological function and pain alleviation were not different among the three groups.Conclusion: Prof. DENG Tie-tao’s CHDC is effective in treating CHD with qi deficiency

关键词

Prof. DENG Tie-taocoronary heart diseaseangina pectorisquality of life

Keywords

Prof. DENG Tie-taocoronary heart diseaseangina pectorisquality of life

references

International Cardiology Association and Society and World Health Organization Clinical Denomination Standard Combined Subject Group. Ischemic heart disease denomination and diagnosis criteria. Chin J Cardiol 1981; 9(1): 75.

Wang JL. editor. Clinical epidemiology-Clinical scientific research’s design and measure and evaluation. 2nd ed. Shanghai: Shanghai Scientific and Technological Press, 2001: 369–373.

Wei CH. The application of the 36 short form of health survey. Foreign Med: Social Med Fascicle 1997; 14(4): 145–147.

Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25(2): 333–341.

Rao ZH, Yuan ZM. A new questionnaire for assessing the functional state of patients with CHD. Foreign Med: Gerontol Fascicle 1996; 17(1): 14–16.

National Symposium on Preventing and Treating Arrhythmia with Integration of TCM and Western Medicine. Coronary heart disease angina pectoris and ECG efficacy criteria. J TCM 1996; 37(10): 583.

Hu MY, Xu J. The application of quality of life in evaluation of pharmacodynamics. Chin Pharm J 1999;34(6): 363–365.

Fredric JP, William AD. Clinical cardiac rehabilitation; A cardiologist’s guide. Tianjin: Tianjin Science-Technological Translation and Publishing Company, 2000: 47–68.

Ware JE, Snow KK, Kosinski M, et al. SF-36 health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993: 1–12.

Kim HK, Hisata M, Kai I, et al. Social support exchange and quality of life among the Korean elderly. J Cross Cult Gerontol 2000; 15: 331–347.

Li L, Wang HM, Shen Y. Development and psychometric test of a Chinese version of the SF-36 Health Survey Scales. Chin J Prev Med 2002; 36(2): 109–113.

Liu TX, Kong SP, Liao ZY, et al. The study of Seattle Angina Questionnaire to evaluating CHD patients functional status and quality of life. Chin J Behavioral Med Sci 1997; 6(2): 127–129.

CASS Principal Investigators and Their Associates. Coronary artery surgery study (CASS): A randomized trial of coronary artery bypass, quality of life in patients randomly assigned to treatment groups. Circulation 1983;68: 951–960.

FULL TEXT LINK

More>

浏览量

436

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Clinical observation on treatment of 45 angina pectoris patients of coronary heart disease with Tianbaoning

Effect of Shenzhu Guanxin Recipe (参术冠心方) on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial

Standardized treatment of chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches